NAVB Navidea Biopharmaceuticals Inc

-0.0041 (-4.4%)
Last Updated: 12:05:27
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 1,087,603
Bid Price
Ask Price
News -
Day High 0.097


52 Week Range


Day Low 0.088
Company Name Stock Ticker Symbol Market Type
Navidea Biopharmaceuticals Inc NAVB AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0041 -4.4% 0.089 12:05:27
Open Price Low Price High Price Close Price Prev Close
0.097 0.088 0.097 0.0931
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
865 1,087,603 $ 0.0905193 $ 98,449 - 0.0626 - 0.35
Last Trade Time Type Quantity Stock Price Currency
12:08:23 10 $ 0.089051 USD

Navidea Biopharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8.89M 99.83M - 66k -17.22M -0.17 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Navidea Biopharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NAVB Message Board. Create One! See More Posts on NAVB Message Board See More Message Board Posts

Historical NAVB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.09230.09880.0880.09456552,528,864-0.0033-3.58%
1 Month0.0790.1450.07650.10486136,628,1610.0112.66%
3 Months0.10240.1450.06260.09933044,861,102-0.0134-13.09%
6 Months0.28460.329550.06260.10087655,291,982-0.1956-68.73%
1 Year0.22920.350.06260.10434832,679,440-0.1402-61.17%
3 Years2.863.150.06260.29610791,010,082-2.77-96.89%
5 Years0.235.35690.06260.6313757837,544-0.141-61.3%

Navidea Biopharmaceuticals Description

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
Your Recent History
Navidea Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now